Schedule 13D ownership disclosure
LOXO ONCOLOGY INC
Security class unavailable · CUSIP: 548862101
Event date: 2017-01-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.7600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-17-000035
- Form type
- SC 13D
- Filer
- Loxo Oncology, Inc.
- CIK
- CIK 1581720
- Filed
- Jan 12, 2017
- Reporting period
- Jan 10, 2017
- Description
- Schedule 13D beneficial ownership